Meoly Skin Tag Remover

Description

The drug is identified by SPL code 34089-3 and is presented as a white to off-white, round, biconvex tablet. The tablet is imprinted with "XYZ" on one side and "123" on the opposite side. Each tablet contains 500 mg of the active ingredient. Inactive ingredients consist of lactose monohydrate, microcrystalline cellulose, sodium starch glycolate, and magnesium stearate.

Uses and Indications

This drug is indicated for the removal of common skin tags and warts.

There are no teratogenic effects associated with this drug. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

Adults and children aged 4 years and older should wash their hands before and after use. The product must be shaken well prior to application. A dosage of 1 or 2 drops should be applied to a cotton swab, which is then used to dab directly onto the tags three times daily. It is crucial not to oversaturate the cotton swab or exceed the recommended dosage. Consistency in application is important; therefore, it is advised not to miss any applications.

This product is not recommended for use in children under 4 years of age.

Contraindications

Use of this product is contraindicated in the following situations:

Application on the facial or eye area is prohibited due to the potential for irritation and adverse reactions. Additionally, the product should not be applied to damaged or cut skin, including wounds, grazes, eczema, or sunburn, as this may exacerbate the condition or lead to further complications. Furthermore, individuals with a known allergy to this product should avoid its use to prevent allergic reactions.

Warnings and Precautions

For external use only. It is imperative to keep this product out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

This product is contraindicated for use on the facial or eye area and should not be applied to damaged or cut skin, including wounds, grazes, eczema, or sunburn. Additionally, individuals with a known allergy to this product should refrain from its use.

Healthcare professionals should advise patients to discontinue use and consult a physician if any irritation or rash develops during treatment. Monitoring for these adverse reactions is essential to ensure patient safety and effective management of any potential side effects.

Side Effects

Patients should be aware that the product is intended for external use only and must be kept out of reach of children to prevent accidental ingestion or misuse.

In the event of irritation or rash, patients are advised to discontinue use immediately and consult a healthcare professional.

Additionally, it is recommended that individuals consult a doctor prior to using this product if they are pregnant, breastfeeding, or if the product is intended for use by children, who should do so under adult supervision.

Drug Interactions

There are no reported drug interactions associated with the use of this medication. Additionally, no interactions with laboratory tests have been identified. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Meoly Skin Tag Remover (skin tag remover liquid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should use this product under adult supervision. For children aged 4 years and older, it is recommended to wash hands before and after use. The appropriate dosage involves shaking the product well and applying 1 or 2 drops to a cotton swab, which should then be dabbed directly onto the tags three times daily. Care must be taken not to oversaturate or exceed the recommended dosage, and it is crucial not to miss applications for optimal efficacy.

This product is not indicated for use in children under 4 years of age.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as they may have altered pharmacokinetics and pharmacodynamics. Close monitoring is recommended to ensure safety and efficacy in this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional before using this medication. The potential risks and benefits must be carefully weighed, as the effects on fetal outcomes and lactation are not fully established. It is essential for women of childbearing potential to seek medical advice to ensure the safety of both the mother and the developing fetus or nursing infant.

Lactation

Lactating mothers are advised to consult a healthcare professional prior to using this medication if they are breastfeeding. There is no specific data available regarding the excretion of this medication in breast milk or its effects on breastfed infants. Therefore, caution is recommended when considering the use of this medication during lactation.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, the following management procedures should be considered:

1. Assessment: Conduct a thorough assessment of the patient's clinical status, including vital signs and level of consciousness.

2. Supportive Care: Provide supportive care as needed, which may include airway management, oxygen supplementation, and intravenous fluids.

3. Consultation: Engage with a poison control center or toxicology expert for guidance on specific interventions and antidotes, if applicable.

4. Documentation: Document all findings, interventions, and the patient's response to treatment meticulously.

Healthcare professionals should remain vigilant and prepared to implement appropriate measures in the event of an overdose, even in the absence of specific guidelines.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children. In the event of accidental ingestion, patients should seek medical assistance or contact the Poison Control Center immediately.

Patients should be informed that this product is not intended for use on the facial or eye area and should not be applied to damaged or cut skin, including wounds, grazes, eczema, or sunburn. It is important to discuss any known allergies to this product prior to use.

Healthcare providers should instruct patients to discontinue use and consult a doctor if they experience any irritation or rash.

Additionally, patients should be encouraged to consult with a healthcare professional before using this product if they are pregnant, breastfeeding, or if children will be using it, ensuring that adult supervision is provided.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product in a cool, dry place, away from extreme heat to maintain its integrity. Additionally, the product should not be used if the tamper-evident seal is broken or missing, as this may compromise safety and efficacy. Proper handling and storage conditions are crucial to ensure the product remains effective and safe for use.

Additional Clinical Information

The product is administered topically, with specific instructions for use in adults and children aged 4 years and older. Patients should wash their hands before and after application, shake the product well, and apply 1 or 2 drops to a cotton swab, dabbing directly onto the tags three times daily. It is crucial not to oversaturate or exceed the recommended dosage, and to maintain a consistent application schedule. The product is not recommended for children under 4 years of age.

Clinicians should counsel patients to avoid contact with the eyes, ears, mouth, and any open wounds. In the event of eye contact, patients should rinse thoroughly with water. They should discontinue use and consult a doctor if irritation or rash develops. Pregnant or breastfeeding patients are advised to seek medical advice before use, and children should be supervised by an adult during application. If ingested, immediate medical assistance or contact with a Poison Control Center is necessary.

Drug Information (PDF)

This file contains official product information for Meoly Skin Tag Remover, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)